SK Biopharmaceuticals-2021 earnings
SK Biopharmaceuticals swings to profits in 2021
SEOUL, Feb. 8 (Yonhap) -- SK Biopharmaceuticals Co. on Tuesday reported its 2021 net income of 83.5 billion won (US$69.7 million), turning from a loss of 247.4 billion won a year earlier.
Operating income for the year was 95.3 billion, compared with a loss of 239.5 billion won from the previous year, the company said in a regulatory filing. Annual sales rose 1510.2 percent to 418.6 billion won.
(END)
(C) Yonhap News Agency. All Rights Reserved
